JPH07103066B2 - Method for producing α-haloenone form - Google Patents

Method for producing α-haloenone form

Info

Publication number
JPH07103066B2
JPH07103066B2 JP4993387A JP4993387A JPH07103066B2 JP H07103066 B2 JPH07103066 B2 JP H07103066B2 JP 4993387 A JP4993387 A JP 4993387A JP 4993387 A JP4993387 A JP 4993387A JP H07103066 B2 JPH07103066 B2 JP H07103066B2
Authority
JP
Japan
Prior art keywords
formula
group
general formula
reaction
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4993387A
Other languages
Japanese (ja)
Other versions
JPS63216838A (en
Inventor
正勝 柴崎
敦男 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute (Sagami CRI)
Original Assignee
Sagami Chemical Research Institute (Sagami CRI)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute (Sagami CRI) filed Critical Sagami Chemical Research Institute (Sagami CRI)
Priority to JP4993387A priority Critical patent/JPH07103066B2/en
Publication of JPS63216838A publication Critical patent/JPS63216838A/en
Publication of JPH07103066B2 publication Critical patent/JPH07103066B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は一般式(I) (式中、X1及びX2は塩素原子、臭素原子又は沃素原子を
表わし、R1は炭素数3〜10の直鎖もしくは分枝鎖アルキ
ル基、又は置換されていないか少なくとも1個の炭素数
1〜4のアルキル基で置換されている炭素数4〜7のシ
クロアルキル基、又は炭素数3〜12の直鎖もしくは分枝
鎖アルケニル基、又は置換されていてもよいフェニル
基、フェノキシ基、もしくはフェノキシアルキル基、又
は炭素数3〜12の直鎖もしくは分枝鎖アルキニル基を表
わす。)で表わされるジハロ−カルボニル化合物を亜鉛
及びジアルキルアルミナムハライドの存在下、一般式
(II) R2−CHO― (II) (式中、R2は置換されていてもよい5員環、置換されて
いてもよいビシクロ〔3.3.0〕オクタン骨格又は置換さ
れていてもよいビシクロ〔4.3.0〕ノナン骨格を表わ
す。)で表わされるアルデヒド体と反応させ、次いで置
換スルホニルクロリド又は無水酢酸、及び塩基で処理す
ることを特徴とする一般式(IV) 〔式中、AはX1又はX2を表わし(X1及びX2は塩素原子、
臭素原子又は沃素原子を表わす。)R1とR2は前記と同様
の意味を表わす。)で表わされるα−ハロエノン体の製
造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention is represented by the general formula (I). (In the formula, X 1 and X 2 represent a chlorine atom, a bromine atom or an iodine atom, and R 1 is a linear or branched alkyl group having 3 to 10 carbon atoms, or an unsubstituted or at least one carbon atom. C4-C7 cycloalkyl group substituted with C1-C4 alkyl group, or C3-C12 linear or branched alkenyl group, or optionally substituted phenyl group, phenoxy group Or a phenoxyalkyl group, or a linear or branched alkynyl group having 3 to 12 carbon atoms) in the presence of zinc and a dialkylaluminum halide in the general formula (II) R 2- CHO- (II) (wherein R 2 is an optionally substituted 5-membered ring, an optionally substituted bicyclo [3.3.0] octane skeleton or an optionally substituted bicyclo [4.3.0] nonane Represents the skeleton) It is reacted with I to the aldehyde, then substituted sulfonyl chloride or acetic anhydride, and the general formula which comprises treating with a base (IV) [In the formula, A represents X 1 or X 2 (X 1 and X 2 are chlorine atoms,
Represents a bromine atom or an iodine atom. ) R 1 and R 2 have the same meanings as described above. And a method for producing an α-haloenone form represented by

本発明の方法を用いることにより下記式(V) で表わされるビシクロ〔3.3.0〕オクタン誘導体も容易
に合成することができる。前記式(V)で表わされるビ
シクロ〔3.3.0〕オクタン誘導体は、15位のカルボニル
基を還元し、塩基で処理することにより、13−14位に三
重結合を容易に導入することができる(特開昭61−2052
22参照)。例えば、下記式(VI)で表わされるオキサ−
カルバサイクリン を高い効率で合成することができる。オキサ−カルバサ
イクリンは、第二世代のカルバサイクリンとして注目さ
れている物質で現在臨床段階にあるカルバサイクリン類
(カルボン酸のβ位酸素原子がメチレンにおきかわった
もの)に比して体内寿命が極めて長い点が特徴である
〔H.Vorbrggen,W.Skuballa and B.Radchel,京都プ
ロスタグランジン会議(京都、November 25,1984),Pro
gram & Abstracts,p36)。
By using the method of the present invention, the following formula (V) The bicyclo [3.3.0] octane derivative represented by can be easily synthesized. The bicyclo [3.3.0] octane derivative represented by the above formula (V) can easily introduce a triple bond at the 13-14 position by reducing the carbonyl group at the 15 position and treating with a base ( JP 61-2052
22). For example, an oxa represented by the following formula (VI)
Carbacyclin Can be synthesized with high efficiency. Oxa-carbacycline is a substance that is drawing attention as a second-generation carbacyclin, and has a longer lifespan in the body than carbacyclins currently in the clinical stage (where the β-position oxygen atom of carboxylic acid replaces methylene) Characterized by extremely long points [H. Vorbrggen, W. Skuballa and B. Radchel, Kyoto Prostaglandin Conference (Kyoto, November 25, 1984), Pro
gram & Abstracts, p36).

〔従来技術〕 前記式(V)中に含まれるα−ハロエノン構造は従来下
記一般式(VII) (式中、R1は前記と同様の意味を表わし、Xは臭素及び
塩素を表わし、R3は低級アルキル基を表わす。)で表わ
される試薬を用いて合成されていた〔W.Skuballa,E.Sch
illinger,C.−st.Strzebecher and H.Vorbrggen,J.
Med.Chem.,29,313(1986)〕。しかしながら該反応は、
用いるアルデヒド体により収率が低いかあるいは全く反
応が進行しない場合があり、一般性のある優れた反応の
開発が持たれていた。
[Prior Art] The α-haloenone structure contained in the above formula (V) is conventionally represented by the following general formula (VII). (Wherein R 1 has the same meaning as described above, X represents bromine and chlorine, and R 3 represents a lower alkyl group.) [W. Skuballa, E] .Sch
illinger, C.-st.Strzebecher and H.Vorbrggen, J.
Med. Chem., 29 , 313 (1986)]. However, the reaction is
Depending on the aldehyde compound used, the yield may be low or the reaction may not proceed at all, and the development of a general and excellent reaction was considered.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明者等は、上記問題点を解決すべく鋭意検討を進め
た結果、前記一般式(I)で表わされるジハローカルボ
ニル化合物が前記一般式(VII)で表わされる試薬より
もはるかに優れた性質を有しておりα−ハロエノン化合
物を容易に製造する方法を見い出す事ができ、本発明を
完成した。
As a result of intensive studies to solve the above problems, the present inventors have found that the dihalocarbonyl compound represented by the general formula (I) is far superior to the reagent represented by the general formula (VII). The present invention has been completed by the fact that a method for producing an α-haloenone compound having properties is easily found.

〔問題点を解決するための手段〕[Means for solving problems]

本発明の原料である前記一般式(I)で表わされるジハ
ロ−カルボニル化合物は以下に記す反応式のいずれかに
従い製造することができる。
The dihalo-carbonyl compound represented by the general formula (I), which is the starting material of the present invention, can be produced according to any of the reaction formulas described below.

(式中、X1,X2及びR1は前記と同様の意味を表わす。) (式中、X1,X2及びR1は前記と同様の意味を表わす。R4
は低級アルキル基である。) 〔反応式(I)第一工程〕 本工程は市販されているかあるいは容易に合成可能な前
記一般式(VII)で表わされるアルデヒド化合物にメチ
レンハライドのカルボアニオンを縮合させ、前記一般式
(IX)で表わされるアルコール体を合成するものであ
る。メチレンハライドのガルボアニオン調製には強塩基
が必要であり、リチウムジイソプロピルアミド、リチウ
ムジシクロヘキシルアミドあるいはリチウムジエチルア
ミド等を使用する。反応は−100℃から0℃の範囲下溶
媒中実施するのが好ましく、テトラヒドロフラン、ジエ
チルエーテル、ジメトキシエタン等のエーテル系溶媒を
使用することができる。
(In the formula, X 1 , X 2 and R 1 have the same meanings as described above.) (In the formula, X 1 , X 2 and R 1 have the same meanings as described above. R 4
Is a lower alkyl group. ) [Reaction Formula (I) First Step] In this step, the carbanion of methylene halide is condensed with the aldehyde compound represented by the general formula (VII) which is commercially available or can be easily synthesized to prepare the general formula (IX). ) Is for synthesizing an alcohol compound. A strong base is necessary for the preparation of the galvanion of methylene halide, and lithium diisopropylamide, lithium dicyclohexylamide, lithium diethylamide or the like is used. The reaction is preferably carried out in a solvent in the range of -100 ° C to 0 ° C, and an ether solvent such as tetrahydrofuran, diethyl ether, dimethoxyethane or the like can be used.

〔反応式(I)第二工程〕[Reaction Formula (I) Second Step]

本工程は、前記第一工程で得られた前記一般式(IX)で
表わされるアルコール体を酸化し、前記一般式(I)で
表わされるジハロ−カルボニル化合物を合成するもので
ある。酸化剤としてはピリジニウムクロロクロメイトや
スワーン酸化剤(オキザリルクロリド−ジメチルスルホ
キシド−トリエチルアミン)が使用できる。いずれの酸
化剤を用いるにしても、反応は溶媒中で行うことが好ま
しく、塩化メチレンやクロロホルム等のハロゲン化炭化
水素溶媒を使用できる。又、反応温度は−8℃から5℃
を選択することができる。
In this step, the alcohol compound represented by the general formula (IX) obtained in the first step is oxidized to synthesize the dihalo-carbonyl compound represented by the general formula (I). As the oxidizing agent, pyridinium chlorochromate and a swerning agent (oxalyl chloride-dimethyl sulfoxide-triethylamine) can be used. Whichever oxidizing agent is used, the reaction is preferably carried out in a solvent, and a halogenated hydrocarbon solvent such as methylene chloride or chloroform can be used. Also, the reaction temperature is -8 ° C to 5 ° C.
Can be selected.

〔反応式(II)第一工程〕[Reaction Formula (II) First Step]

本工程は、市販されているかあるいは容易に合成可能な
前記一般式(X)で表わされるエステル体にメチレンハ
ライドのカルボアニオンを縮合させ、前記一般式(I)
で表わされるジハロ−カルボニル化合物を製造するもの
である。反応に使用する試薬、反応条件等は、前記〔反
応式(I)第一工程〕と全く同じである。
In this step, the carbanion of methylene halide is condensed with the ester represented by the general formula (X), which is commercially available or can be easily synthesized, to give the general formula (I).
To produce a dihalo-carbonyl compound. The reagents and reaction conditions used in the reaction are exactly the same as those in the above [Reaction formula (I) first step].

前記一般式(I)で表わされるジハロ−カルボニル化合
物は、以下の反応式に従いα−ハロエノン体へ変換する
事ができる。
The dihalo-carbonyl compound represented by the general formula (I) can be converted into an α-haloenone compound according to the following reaction formula.

(式中、X1,X2,A,R1及びR2は前記と同様の意味を表わ
し、R5は置換スルホニル基又はアセチル基を表わす。) 〔第一工程〕 本工程は、前記一般式(I)で表わされるジハロ−カル
ボニル化合物を亜鉛末存在下ジアルキルアルミナムハラ
イドと反応させアルミナムエノラートとし、前記一般式
(II)で表わされるアルデヒド体と縮合させて前記一般
式(III)で表わされるアルコール体を製造するもので
ある。本反応は溶媒中で実施するものであり、テトラヒ
ドロフラン、エーテル、ジメトキシエタン等のエーテル
系溶媒を使用する。使用するジアルキルアルミナムハラ
イドとしては、ジメチルアルミナムクロリド、ジエチル
アルミナムクロリド等が特に好ましい。反応は−50℃か
ら室温の範囲で円滑に進行する。
(In the formula, X 1 , X 2 , A, R 1 and R 2 have the same meanings as described above, and R 5 represents a substituted sulfonyl group or an acetyl group.) [First Step] A dihalo-carbonyl compound represented by the formula (I) is reacted with a dialkylaluminum halide in the presence of zinc powder to form an alumina enolate, which is condensed with an aldehyde derivative represented by the general formula (II) to be represented by the general formula (III). It is for producing an alcohol body. This reaction is carried out in a solvent, and an ether solvent such as tetrahydrofuran, ether or dimethoxyethane is used. As the dialkylaluminum halide used, dimethylaluminum chloride, diethylaluminum chloride and the like are particularly preferable. The reaction proceeds smoothly in the range of -50 ° C to room temperature.

〔第二工程〕[Second step]

本工程は、前記第一工程で得られた前記一般式(III)
で表わされるアルコール体を前記一般式(XI)で表わさ
れるスルホニルオキシ体又はアセテート体へ変換するも
のである。本反応は溶媒中で実施するものであり、塩化
メチレン、クロロホルム等のハロゲン化炭化水素溶媒、
もしくはピリジン等の溶媒を用いることができる。反応
試剤としては、メタンスルホニルクロリド、パラトルエ
ンスルホニルクロリド等の置換スルホニルクロリド又は
無水酢酸などを使用する。ハロゲン化炭化水素溶媒中で
反応を実施する時は、塩基としてトリエチルアミンの存
在下に反応を実施する。反応は−78℃から−15℃の範囲
で円滑に進行する。
This step is carried out by the general formula (III) obtained in the first step.
The alcoholic body represented by the above formula is converted into the sulfonyloxy body or the acetate body represented by the general formula (XI). This reaction is carried out in a solvent, and a halogenated hydrocarbon solvent such as methylene chloride or chloroform,
Alternatively, a solvent such as pyridine can be used. As the reaction reagent, a substituted sulfonyl chloride such as methanesulfonyl chloride or paratoluenesulfonyl chloride, or acetic anhydride is used. When the reaction is carried out in a halogenated hydrocarbon solvent, the reaction is carried out in the presence of triethylamine as a base. The reaction proceeds smoothly in the range of -78 ° C to -15 ° C.

〔第三工程〕[Third step]

本工程は、前記第一工程で得られた前記一般式(XI)で
表わされるスルホニルオキシ体をトリエチルアミンない
しはピリジンあるいはDBUの存在下、−10℃から室温で
処理することにより前記一般式(IV)で表わされるα−
ハロエノン体を製造するものである。反応は塩化メチレ
ンやクロロホルム等のハロゲン化炭化水素溶媒、もしく
はピリジン等の溶媒中実施する。なお後記実施例で示さ
れるごとく、反応条件を巧みに選ぶことにより、第二工
程、第三工程を同一フラスコ中で行う事も容易である。
In this step, the sulfonyloxy derivative represented by the general formula (XI) obtained in the first step is treated at −10 ° C. to room temperature in the presence of triethylamine or pyridine or DBU to obtain the general formula (IV). Α-
It is for producing a haloenone form. The reaction is carried out in a halogenated hydrocarbon solvent such as methylene chloride or chloroform, or a solvent such as pyridine. As will be shown in Examples below, it is easy to carry out the second step and the third step in the same flask by judiciously selecting the reaction conditions.

以下、参考例、実施例により本発明を更に詳細に説明す
る。
Hereinafter, the present invention will be described in more detail with reference to Reference Examples and Examples.

参考例1 アルゴン雰囲気下、1−メチル−3−ヘプチナール(3.
3g,25.8mmol)及びジブロモメタン(3.6ml,51.6mmol)
をTHF(50ml)に溶解した。−78℃にてリチウムジシ
クロヘキシルアミドのTHF溶液(20ml,51.6mmol)を30分
間で滴下した。−78℃にて60分間攪拌した後、同温にて
飽和塩化アンモニウム水溶液を加えた。反応液にエーテ
ルを加え不溶物をセライトにてろ過し、エーテル抽出し
た。エーテル層を飽和食塩水にて洗浄し無水硫酸マグネ
シウムで乾燥後、溶媒を留去し1,1−ジブロモ−3−メ
チル−5−オクチン−2−オールの粗生成物(5.49g)
を得た。
Reference example 1 1-methyl-3-heptinal (3.
3g, 25.8mmol) and dibromomethane (3.6ml, 51.6mmol)
Was dissolved in THF (50 ml). Lithium dice at -78 ° C
A solution of chlorhexylamide in THF (20 ml, 51.6 mmol) was added dropwise over 30 minutes. After stirring at −78 ° C. for 60 minutes, a saturated ammonium chloride aqueous solution was added at the same temperature. Ether was added to the reaction solution and the insoluble matter was filtered through Celite, and extracted with ether. The ether layer was washed with saturated brine and dried over anhydrous magnesium sulfate, and the solvent was evaporated to give a crude product of 1,1-dibromo-3-methyl-5-octin-2-ol (5.49 g).
Got

アルゴン雰囲気下、1,1−ジブロモ−3−メチル−5−
オクチン−2−オール(5.49g,18.4mmol)を塩化メチレ
ン(60ml)に溶解し粉末の4A−モレキュラーシーブス
(5.49g)及びPCC(7.9g,36.8mmol)を加え2日間攪拌
した。反応液にエーテルを加えた後フローリジルカラム
クロマトグラフィー(エーテル)にて反応液をろ過しエ
ーテルで洗浄し、溶媒を留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィー(エーテル:n−ヘキ
サン=1:40)にて精製し、1,1−ジブロモ−3−メチル
−5−オクチニル−2−オン(4.52g,83%)を得た。
Under an argon atmosphere, 1,1-dibromo-3-methyl-5-
Octin-2-ol (5.49 g, 18.4 mmol) was dissolved in methylene chloride (60 ml), powdered 4A-molecular sieves (5.49 g) and PCC (7.9 g, 36.8 mmol) were added, and the mixture was stirred for 2 days. After adding ether to the reaction solution, the reaction solution was filtered by flow lysyl column chromatography (ether) and washed with ether, and the solvent was distilled off. The obtained residue was purified by silica gel column chromatography (ether: n-hexane = 1: 40), 1,1-dibromo-3-methyl-5-octynyl-2-one (4.52 g, 83%) Got

IR(neat):3000,2950,1740,1450,1380,1320,1000,700c
m-1 NMR(CDCl3)δ:6.0(s,1H),2.23(m,5H),1.26(d,J
=7.5Hz,3H),1.06(t,J=12Hz,3H) Mass(m/z):215(M+−79,7),136(26),124(75),12
3(100) 参考例2 参考例1と同様の方法によりヘキサナール、(R)−
(+)−β−シトロネラール、シクロヘキサンカルボキ
シアルデヒド、フェノキシアセトアルデヒド、2β−メ
チル−4−ヘプチニルアルデヒドよりそれぞれ対応する
ジブロモケトン化合物を合成した。以下の表Iに収率及
びIR,NMRのスペクトルデータを示す。
IR (neat): 3000,2950,1740,1450,1380,1320,1000,700c
m -1 NMR (CDCl 3 ) δ: 6.0 (s, 1H), 2.23 (m, 5H), 1.26 (d, J
= 7.5Hz, 3H), 1.06 (t, J = 12Hz, 3H) Mass (m / z): 215 (M + −79,7), 136 (26), 124 (75), 12
3 (100) Reference example 2 By the same method as in Reference Example 1, hexanal, (R)-
Corresponding dibromoketone compounds were synthesized from (+)-β-citronellal, cyclohexanecarboxaldehyde, phenoxyacetaldehyde, and 2β-methyl-4-heptynylaldehyde. The yield and IR and NMR spectrum data are shown in Table I below.

参考例8 アルゴン雰囲気下、−100℃にてリチウムジイソプロピ
ルアミドのエーテル−THF(40ml,容積比,3:1,20mmol)
にメチレンジブロミド(3.8g,22mmol)のTHF溶液(20m
l)を加え同温にて15分間攪拌した。−100℃にてメチル
−2−メチル−4−ヘプチネイト(1.54g,10mmol)のTH
F溶液(10ml)を滴下し−100〜−60℃にて2時間30分攪
拌した。反応液に10%塩酸水溶液を滴下しエーテル層を
水及び飽和食塩水にて洗浄した後無水硫酸マグネシウム
で乾燥した。溶媒を留去して得られた残留物をシリカゲ
ルカラムクロマトグラフィー(エーテル:n−ヘキサン=
1:40)にて精製し1,1−ジブロモ−3−メチル−5−オ
クチニル−2−オン(2.51g,85%)を得た。IR(nea
t):3000,2950,1740,1450,1380,1320,1000,700cm-1 NMR(CDCl3)δ:6.00(s,1H),2.23(m,5H),1.26(d,J
=7.5Hz,3H),1.06(t,12Hz,3H) Mass(m/z):215(M+−79,7),136(26),124(75),12
3(100) 参考例9〜10 参考例8と同様の方法によりカプロン酸メチルエステ
ル、フエノキシ酢酸メチルエステルよりそれぞれ対応す
るジブロモケトン化合物を76%、83%で合成した。それ
らのスペクトルデータは参考例3及び参考例6で得られ
た化合物と一致した。
Reference example 8 Lithium diisopropylamide ether-THF (40 ml, volume ratio, 3: 1, 20 mmol) at −100 ° C. under argon atmosphere.
Solution of methylene dibromide (3.8g, 22mmol) in THF (20m
l) was added and the mixture was stirred at the same temperature for 15 minutes. Methyl-2-methyl-4-heptinate (1.54g, 10mmol) TH at -100 ° C
The F solution (10 ml) was added dropwise, and the mixture was stirred at -100 to -60 ° C for 2 hours and 30 minutes. A 10% aqueous hydrochloric acid solution was added dropwise to the reaction solution, the ether layer was washed with water and saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off and the obtained residue was subjected to silica gel column chromatography (ether: n-hexane =
1:40) to obtain 1,1-dibromo-3-methyl-5-octynyl-2-one (2.51 g, 85%). IR (nea
t): 3000, 2950, 1740, 1450, 1380, 1320, 1000, 700 cm -1 NMR (CDCl 3 ) δ: 6.00 (s, 1H), 2.23 (m, 5H), 1.26 (d, J
= 7.5Hz, 3H), 1.06 (t, 12Hz, 3H) Mass (m / z): 215 (M + −79,7), 136 (26), 124 (75), 12
3 (100) Reference Examples 9-10 In the same manner as in Reference Example 8, corresponding dibromoketone compounds were synthesized from caproic acid methyl ester and phenoxyacetic acid methyl ester at 76% and 83%, respectively. The spectral data of them were in agreement with those of the compounds obtained in Reference Examples 3 and 6.

実施例1 アルゴン雰囲気下、亜鉛末(17.8mg,0.274mmol)及び触
媒量の臭化第一銅をTHF(1ml)に懸濁させた。室温にて
ジエチルアルミニウムクロライド(1.44Mヘキサン溶液,
0.19ml,0.274mmol)を加え同温にて10分間攪拌した。−
5℃にて〔3E−(4−t−ブロキシカルボニル−3−オ
キサ−ブチリデン)−6−エキソ−ホルミル−7−エン
ド−テトラヒドロピラニルオキシ−シス−ビシクロ〔3.
3.0〕オクタン〕(45mg,0.14mmol)及び1,1−ジブロモ
−3β−メチル−5−オクチニル−2−オン(170mg,0.
576mmol)のTHF溶液(2ml)を15分間かけてゆっくり滴
下した後、同温にて60分間攪拌した。反応液に飽和炭酸
水素カリウム水溶液を加え、エーテル抽出、エーテル層
を飽和食塩水にて洗浄した後無水硫酸マグネシウムで乾
燥した。溶媒を留去し、得られた残留物を塩化メチレン
(2ml)に溶解し、−20℃にてトリエチルアミン(0.29m
l,2.1mmol)を加えた後、メタンスルホニルクロライド
(0.054ml,0.7mmol)を滴下し0℃にて15時間攪拌し
た。反応液に氷水を加え、エーテル抽出した。エーテル
層を水及び飽和食塩水にて洗浄後、無水硫酸マグネシウ
ムで乾燥し溶媒を留去した。得られた残留物をシリカゲ
ルカラムクロマトグラフィー(エーテル:n−ヘキサン=
1:3)にて精製し〔3E−(4−t−ブトキシカルボニル
−3−オキサ−ブチリデン)−6−エキソ−(2−ブロ
モ−3−オキソ−4β−メチル−トランス−1−ノネン
−6−イニル)−7−エンド−テトラヒドロピラニルオ
キシ−シス−ビシクロ〔3.3.0〕オクタン〕(45mg,67
%)を得た。
Example 1 Zinc dust (17.8 mg, 0.274 mmol) and a catalytic amount of cuprous bromide were suspended in THF (1 ml) under an argon atmosphere. Diethyl aluminum chloride at room temperature (1.44M hexane solution,
0.19 ml, 0.274 mmol) was added and the mixture was stirred at the same temperature for 10 minutes. −
[3E- (4-t-Broxycarbonyl-3-oxa-butylidene) -6-exo-formyl-7-endo-tetrahydropyranyloxy-cis-bicyclo [3.
3.0] Octane] (45 mg, 0.14 mmol) and 1,1-dibromo-3β-methyl-5-octynyl-2-one (170 mg, 0.
A THF solution (2 ml) of 576 mmol) was slowly added dropwise over 15 minutes, and then the mixture was stirred at the same temperature for 60 minutes. A saturated aqueous solution of potassium hydrogen carbonate was added to the reaction solution, which was extracted with ether. The ether layer was washed with saturated saline and then dried over anhydrous magnesium sulfate. The solvent was evaporated, the obtained residue was dissolved in methylene chloride (2 ml), and triethylamine (0.29 m
(1, 2.1 mmol) was added, methanesulfonyl chloride (0.054 ml, 0.7 mmol) was added dropwise, and the mixture was stirred at 0 ° C. for 15 hours. Ice water was added to the reaction solution, and the mixture was extracted with ether. The ether layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated. The obtained residue was subjected to silica gel column chromatography (ether: n-hexane =
1: 3) and purified [3E- (4-t-butoxycarbonyl-3-oxa-butylidene) -6-exo- (2-bromo-3-oxo-4β-methyl-trans-1-nonene-6. -Inyl) -7-endo-tetrahydropyranyloxy-cis-bicyclo [3.3.0] octane] (45 mg, 67
%) Was obtained.

IR(neat):2930,2850,1740,1690,1200,820 NMR(CDCl3)δ:7.10(dd,J=9Hz,1H),5.53(t,J=12H
z,1H),4.66,4.53(eachbs,totallH),4.10(d,J=7.5H
z,2H),3.96(s,2H),1.16(d,J=7Hz,2H),1.06(t,J
=7.5Hz,3H) Mass(m/z):379(5),378(11),376(11),105(2
6),85(100),79(12),67(42),57(95),55(31),
43(37),41(67),29(30) 実施例2 アルゴン雰囲気下、亜鉛末(19.6mg,0.3mmol)及び触媒
量の臭化第一銅をTHF(1ml)に懸濁させた。室温にてジ
エチルアルミニウムクロライド(1.15Mヘキサン溶液,0.
26ml,0.3mmol)を加え同温にて10分間攪拌した。−5℃
にて〔3E−(2−メトキシ−エチリデン)−6−エキソ
−ホルミル−7−エンド−テトラヒドロピラニルオキシ
−シス−ビシクロ〔3.3.0〕オクタン〕(74mg,0.252mmo
l)及び1,1−ジブロモ−2−ヘプタノン(171mg,0.63mm
ol)のTHF溶液(2ml)を15分間かけて滴下した後、同温
にて40分間攪拌した。反応液に飽和炭酸水素カリウム水
溶液を加えた後エーテル抽出、エーテル層を飽和食塩水
にて洗浄し無水硫酸マグネシウムで乾燥した。溶媒を留
去し、得られた残留物を塩化メチレン(2ml)に溶解し
た。−20℃にてトリエチルアミン(0.57ml,4.16mmol)
を加えた後、メタンスルホニルクロライド(0.108ml,1.
37mmol)を滴下し0℃にて二時間攪拌した。反応液に氷
水を加えエーテル抽出、エーテル層を水及び飽和食塩水
にて洗浄し無水硫酸マグネシウムで乾燥後、溶媒を留去
した。得られた残留物をシリカゲルカラムクロマトグラ
フィー(エーテル:n−ヘキサン=1:4)にて精製し〔3E
−(メトキシ−エチリデン)−6−エキソ−(2−ブロ
モ−3−オキソ−トランス−1−オクテニル)−7−エ
ンド−テトラヒドロピラニルオキシ−シス−ビシクロ
〔3.3.0〕オクタン〕(92mg,75%)を得た。
IR (neat): 2930, 2850, 1740, 1690, 1200, 820 NMR (CDCl 3 ) δ: 7.10 (dd, J = 9Hz, 1H), 5.53 (t, J = 12H
z, 1H), 4.66,4.53 (eachbs, totallH), 4.10 (d, J = 7.5H
z, 2H), 3.96 (s, 2H), 1.16 (d, J = 7Hz, 2H), 1.06 (t, J
= 7.5Hz, 3H) Mass (m / z): 379 (5), 378 (11), 376 (11), 105 (2
6), 85 (100), 79 (12), 67 (42), 57 (95), 55 (31),
43 (37), 41 (67), 29 (30) Example 2 Under an argon atmosphere, zinc dust (19.6 mg, 0.3 mmol) and a catalytic amount of cuprous bromide were suspended in THF (1 ml). Diethyl aluminum chloride (1.15M hexane solution, 0.
(26 ml, 0.3 mmol) was added and the mixture was stirred at the same temperature for 10 minutes. -5 ° C
At [3E- (2-methoxy-ethylidene) -6-exo-formyl-7-endo-tetrahydropyranyloxy-cis-bicyclo [3.3.0] octane] (74 mg, 0.252 mmo
l) and 1,1-dibromo-2-heptanone (171mg, 0.63mm
ol) in THF (2 ml) was added dropwise over 15 minutes, and the mixture was stirred at the same temperature for 40 minutes. A saturated aqueous solution of potassium hydrogen carbonate was added to the reaction solution, followed by extraction with ether. The ether layer was washed with saturated saline and dried over anhydrous magnesium sulfate. The solvent was evaporated, and the obtained residue was dissolved in methylene chloride (2 ml). Triethylamine (0.57ml, 4.16mmol) at -20 ℃
After the addition of methanesulfonyl chloride (0.108 ml, 1.
(37 mmol) was added dropwise and the mixture was stirred at 0 ° C. for 2 hours. Ice water was added to the reaction solution, which was extracted with ether. The ether layer was washed with water and saturated brine and dried over anhydrous magnesium sulfate, and the solvent was evaporated. The obtained residue was purified by silica gel column chromatography (ether: n-hexane = 1: 4) [3E
-(Methoxy-ethylidene) -6-exo- (2-bromo-3-oxo-trans-1-octenyl) -7-endo-tetrahydropyranyloxy-cis-bicyclo [3.3.0] octane] (92 mg, 75 %) Was obtained.

NMR(CDCl3)δ:7.06(dd,J=9Hz,1H),5.50(t,J=12H
z,1H),4.66,4.53(eachbs,total,lH),3.90(d,J=7H
z,2H),3.30(s,3H),0.86(t,J=9Hz,3H) 実施例3〜6 実施例2と同様の方法により〔3E−(2−メトキシ−エ
チリデン)−6−エキソ−ホルミル−7−エンド−テト
ラヒドロピラニルオキシ−シス−ビシクロ〔3.3.0〕オ
クタン〕とジブロモケトン化合物との反応により以下の
化合物を合成した。その収率及びNMRデータを表2にて
示す。
NMR (CDCl 3 ) δ: 7.06 (dd, J = 9Hz, 1H), 5.50 (t, J = 12H
z, 1H), 4.66,4.53 (eachbs, total, lH), 3.90 (d, J = 7H
z, 2H), 3.30 (s, 3H), 0.86 (t, J = 9Hz, 3H) Examples 3 to 6 In the same manner as in Example 2, [3E- (2-methoxy-ethylidene) -6-exo-formyl-7-endo-tetrahydropyranyloxy-cis-bicyclo [3.3.0] octane] and dibromoketone compound were prepared. The following compounds were synthesized by the reaction. The yield and NMR data are shown in Table 2.

実施例7 アルゴン雰囲気下、亜鉛末(11.0mg,0.17mmol)及び触
媒量の臭化第一銅をTHF(1ml)に懸濁させた。室温にて
ジエチルアルミニウムクロライド(1.15Mヘキサン溶液,
0.134ml,0.14mmol)を滴下し同温にて10分間攪拌した。
0℃にて〔3−(4−t−メトキシカルボニル−1−ブ
テニル)−7−エキソ−ホルミル−8−エンド−テトラ
ヒドロピラニルオキシ−シス−ビシクロ〔4.3.0〕ノナ
−2−エン〕(50mg,0.14mmol)及び3,3−ジブロモ−シ
クロヘキサン−2−オン(100mg,0.35mmol)のTHF溶液
(1.5ml)を滴下し同温にて30分間攪拌した。反応液に
飽和炭酸水素カリウム水溶液を加え、エーテル抽出、エ
ーテル層を飽和食塩水にて洗浄した後無水硫酸マグネシ
ウムで乾燥した。溶媒を留去し、得られた残留物を塩化
メチレン(1ml)に溶解し−20℃にてトリエチルアミン
(0.207ml,1.5mmol)を加えた後、メタンスルホニルク
ロライド(0.039ml,0.5mmol)を滴下し室温にて1時間
攪拌した。反応液に氷水を加え、エーテル抽出した。エ
ーテル層を水及び飽和食塩水にて洗浄後、無水硫酸マグ
ネシウムで乾燥し溶媒を留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィー(エーテル:n−ヘキ
サン=1:2)にて精製し〔3−(4−メトキシカルボニ
ル−1−ブテニル)−7−エキソ−(2−ブロモ−3−
オキソ−4−シクロヘキサン−トランス−1−プロペニ
ル)−8−エンド−テトラヒドロピラニルオキシ−シス
−ビシクロ〔4.3.0〕ノナ−2−エン〕(55mg,71%)を
得た。
Example 7 Under an argon atmosphere, zinc dust (11.0 mg, 0.17 mmol) and a catalytic amount of cuprous bromide were suspended in THF (1 ml). Diethyl aluminum chloride (1.15M hexane solution,
0.134 ml, 0.14 mmol) was added dropwise and the mixture was stirred at the same temperature for 10 minutes.
[3- (4-t-methoxycarbonyl-1-butenyl) -7-exo-formyl-8-endo-tetrahydropyranyloxy-cis-bicyclo [4.3.0] non-2-ene] ( A THF solution (1.5 ml) of 50 mg, 0.14 mmol) and 3,3-dibromo-cyclohexane-2-one (100 mg, 0.35 mmol) was added dropwise, and the mixture was stirred at the same temperature for 30 minutes. A saturated aqueous solution of potassium hydrogen carbonate was added to the reaction solution, which was extracted with ether. The ether layer was washed with saturated saline and then dried over anhydrous magnesium sulfate. The solvent was evaporated, the obtained residue was dissolved in methylene chloride (1 ml), triethylamine (0.207 ml, 1.5 mmol) was added at -20 ° C, and then methanesulfonyl chloride (0.039 ml, 0.5 mmol) was added dropwise. Then, the mixture was stirred at room temperature for 1 hour. Ice water was added to the reaction solution, and the mixture was extracted with ether. The ether layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated. The obtained residue was purified by silica gel column chromatography (ether: n-hexane = 1: 2) [3- (4-methoxycarbonyl-1-butenyl) -7-exo- (2-bromo-3-
Oxo-4-cyclohexane-trans-1-propenyl) -8-endo-tetrahydropyranyloxy-cis-bicyclo [4.3.0] non-2-ene] (55 mg, 71%) was obtained.

IR(neat):2940,2860,1730,1680,1200,810cm-1 NMR(CDCl3)δ:7.01(dd,J=1.5,9Hz,1/2H),6.86(d
d,J=3,12Hz,1/2H),6.13(d,J=16Hz,1/3H),5.85(d,
J=12Hz,2/3H),5.60(bs,1H),5.30(m,1H),4.60(m,
1H),3.70(s,3H) Mass(m/z):463(M+−85,trace),314(11),244(2
8),85(100)。
IR (neat): 2940,2860,1730,1680,1200,810cm -1 NMR (CDCl 3 ) δ: 7.01 (dd, J = 1.5,9Hz, 1 / 2H), 6.86 (d
d, J = 3,12Hz, 1 / 2H), 6.13 (d, J = 16Hz, 1 / 3H), 5.85 (d,
J = 12Hz, 2 / 3H), 5.60 (bs, 1H), 5.30 (m, 1H), 4.60 (m,
1H), 3.70 (s, 3H) Mass (m / z): 463 (M + −85, trace), 314 (11), 244 (2
8), 85 (100).

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07C 49/813 69/738 Z 9279−4H C07D 309/12 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location C07C 49/813 69/738 Z 9279-4H C07D 309/12

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式 (式中、X1及びX2は塩素原子、臭素原子又は沃素原子を
表わし、R1は炭素数3〜10の直鎖もしくは分枝鎖アルキ
ル基、又は置換されていないか少なくとも1個の炭素数
1〜4のアルキル基で置換されている炭素数4〜7のシ
クロアルキル基、又は炭素数3〜12の直鎖もしくは分枝
鎖アルケニル基、又は置換されていてもよいフェニル
基、フェノキシ基、もしくはフェノキシアルキル基、又
は炭素数3〜12の直鎖もしくは分枝鎖アルキニル基を表
わす。)で表わされるジハロ−カルボニル化合物を亜鉛
及びジアルキルアルミナムハライドの存在下、一般式 R2−CHO (式中、R2は置換されていてもよい5員環、置換されて
もよいビシクロ〔3.3.0〕オクタン骨格又は置換されて
いてもよいビシクロ〔4.3.0〕ノナン骨格を表わす。)
で表わされるアルデヒド体と反応させ、次いで置換スル
ホニルクロリド又は無水酢酸、及び塩基で処理すること
を特徴とする一般式 〔式中、AはX1又はX2を表わし(X1及びX2は塩素原子、
臭素原子又は沃素原子である。)、R1とR2は前記と同様
の意味を表わす。〕で表わされるα−ハロエノン体の製
造方法。
1. A general formula (In the formula, X 1 and X 2 represent a chlorine atom, a bromine atom or an iodine atom, and R 1 is a linear or branched alkyl group having 3 to 10 carbon atoms, or an unsubstituted or at least one carbon atom. C4-C7 cycloalkyl group substituted with C1-C4 alkyl group, or C3-C12 linear or branched alkenyl group, or optionally substituted phenyl group, phenoxy group Or a phenoxyalkyl group, or a linear or branched alkynyl group having 3 to 12 carbon atoms) in the presence of zinc and a dialkylaluminum halide, represented by the general formula R 2 -CHO (formula In the formula, R 2 represents an optionally substituted 5-membered ring, an optionally substituted bicyclo [3.3.0] octane skeleton or an optionally substituted bicyclo [4.3.0] nonane skeleton.)
A general formula characterized by reacting with an aldehyde derivative represented by and then treating with a substituted sulfonyl chloride or acetic anhydride and a base. [In the formula, A represents X 1 or X 2 (X 1 and X 2 are chlorine atoms,
It is a bromine atom or an iodine atom. ), R 1 and R 2 have the same meanings as described above. ] The manufacturing method of the (alpha)-halo enone body represented by these.
JP4993387A 1987-03-06 1987-03-06 Method for producing α-haloenone form Expired - Lifetime JPH07103066B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4993387A JPH07103066B2 (en) 1987-03-06 1987-03-06 Method for producing α-haloenone form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4993387A JPH07103066B2 (en) 1987-03-06 1987-03-06 Method for producing α-haloenone form

Publications (2)

Publication Number Publication Date
JPS63216838A JPS63216838A (en) 1988-09-09
JPH07103066B2 true JPH07103066B2 (en) 1995-11-08

Family

ID=12844818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4993387A Expired - Lifetime JPH07103066B2 (en) 1987-03-06 1987-03-06 Method for producing α-haloenone form

Country Status (1)

Country Link
JP (1) JPH07103066B2 (en)

Also Published As

Publication number Publication date
JPS63216838A (en) 1988-09-09

Similar Documents

Publication Publication Date Title
JP2003521546A (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
WO2014094511A1 (en) Intermediates for synthesizing treprostinil and preparation method thereof as well as the preparation method of treprostinil thereby
JPH07103066B2 (en) Method for producing α-haloenone form
JP3298929B2 (en) Novel method for producing carboxylic acid ester or carboxylic acid thioester
JP3565587B2 (en) Novel synthesis of 15-hydroxymilbemycin derivatives
JP2664841B2 (en) Process for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo [3.3.0] octanes
WO1998021179A1 (en) Process for the preparation of prostaglandins
JP2662607B2 (en) Bicyclo [8.3.0] trideca-9,13-diene-2,7-diyne derivative
JPH047755B2 (en)
JPH05229975A (en) Cyclopentenol derivative
JP2737214B2 (en) Method for producing 4-hydroxy-2-cyclopentenone derivative
JP3403761B2 (en) 3,5-Dihydroxy-1-octen-7-ynes and method for producing the same
JP4000599B2 (en) Substituted cyclopentene derivatives and process for producing the same
JPH0798796B2 (en) Method for producing isocarbacyclines
JPH053863B2 (en)
JPH07252174A (en) Production of optically active alcohol by asymmetric hydrosilylation of ketone
JPH0220616B2 (en)
JPH0586768B2 (en)
EP1357106A1 (en) Method of synthesizing alpha-ketol unsaturated fatty acid
JPH026341B2 (en)
JPH06104639B2 (en) Method for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo [3.3.0 octanes
JPH0517374A (en) New synthetic method of allene
JPH07247241A (en) New production of carboxylic acid ester
JPH0578540B2 (en)
JPS6251640A (en) Production of isocarbacyclins